# SCRIMED Investor And Audience Readiness

Updated: 2026-07-30

SCRIMED Investor and Audience Readiness turns known weaknesses into owned relief tracks and packages the company for distinct capital, clinic, buyer, and partner audiences. It is designed to strengthen competitive edge, sellable value, and diligence readiness without creating securities, valuation, legal, tax, donor, clinical, PHI, reimbursement, customer-proof, partnership, or approval claims.

## Public Surface

- Page: `/investor-audience-readiness`
- API: `/api/investor-audience-readiness`
- Brief: `/api/investor-audience-readiness/brief`
- Target meeting packet: `/api/investor-audience-readiness/meeting-packet?target=openai&format=markdown`
- Status: `investor-audience-readiness-control-plane-active`
- Brief status: `investor-audience-readiness-brief-ready-no-securities-offer`

## Parallel Pre-Fundraise Lane

SCRIMED now distinguishes three separate readiness states:

1. Internal preparation may continue while candidate review is open.
2. Public-safe discovery conversations and published demo sharing are `REQUIRE_HUMAN`; they use only approved public routes and never send themselves.
3. Investor-deck distribution, controlled diligence, and any securities process remain `BLOCK` until a clean candidate, named independent review, exact SHA-256 bindings, deck approvals, release-steward approval, and applicable customer or counsel permissions exist.

The deterministic policy preview currently exposes six executable synthetic demos and four governed pilot offers from the canonical demo/pilot registry. It labels the preview as synthetic readiness evidence, not current external approval evidence.

The evaluator never performs outreach, submits a startup-program application, opens a data room, or distributes a deck. Even fully satisfied external-release inputs return `REQUIRE_HUMAN`, preserving a named operator as the final actor.

## Weakness Relief Tracks

The control plane explicitly contains ten current weaknesses:

- Fundraising story compression.
- Generic healthcare AI differentiation risk.
- Enterprise legal, finance, accounting, tax, margin, and contract credibility.
- Faith-based clinic and mission-led investment boundaries.
- Buyer-specific proof release friction.
- Clinical and PHI boundary framing.
- Corporate strategic-investor pathway clarity.
- Private-investor unit-economics pressure before mature cohorts.
- Global and public-sector region-specific approval paths.
- First-time audience navigation overload.

Each weakness has an owner, workaround, proof route, success metric, graduation gate, and blocked-claim list.

## Audience Packets

The readiness layer packages SCRIMED for:

- Angel investors and early healthcare operators.
- Large corporate strategic investors.
- Private investors and growth-equity reviewers.
- Faith-based clinics and mission-led clinic investors.
- Health system executives.
- Payers and revenue-cycle buyers.
- Public-sector, grant, and community health funders.
- Clinician advisors and medical leadership.
- Global partners and regional distributors.
- Enterprise innovation and transformation sponsors.

Each packet contains a primary question, sellable value, pitch angle, proof routes, diligence packet, next move, required review, and blocked claims.

## Strategic Ecosystem Outreach

The control plane now includes distinct, evidence-backed preparation packets for OpenAI, NVIDIA, Anthropic, and Microsoft. These are strategic ecosystem targets, not claimed investors or partners. Each packet contains:

- The official startup or partner-program source.
- A company-specific SCRIMED fit thesis.
- A concrete first ask.
- Product and governance proof routes.
- Diligence requirements.
- Explicit claim boundaries.

The associated diligence manifest separates `evidence-ready`, `qualified-review-required`, and `external-evidence-required` items across company narrative, product, safety, security, commercial proof, finance, legal, and clinical/regulatory readiness.

No external outreach, program application, investment request, or partnership communication is sent by this module.

## Strategic Meeting Room

The control plane now provides internal meeting-preparation packets for OpenAI, NVIDIA, Anthropic, and Microsoft. Every packet contains:

- A first-meeting objective and explicit non-goal.
- A concise opening narrative.
- Official-source strategic signals with a SCRIMED implication.
- A timed 30-minute agenda.
- A four-step no-PHI demo sequence.
- Evidence-backed answers to recurring diligence questions.
- One specific ask and one mutual next step.
- Release requirements and forbidden claims.

The OpenAI path deliberately begins with OpenAI for Startups and healthcare technical discovery. SCRIMED has not verified a public general-purpose direct-investment application, so the meeting packet does not frame startup ecosystem access as an investment offer. Any financing conversation requires a permissioned introduction plus founder, counsel, finance, claims, and release-steward approval.

The route supports `target=openai|nvidia|anthropic|microsoft` and `format=json|markdown`. Unsupported targets and formats fail closed with a `400` response. Every response states that external fundraising release is not authorized, no outreach has been sent, and no strategic relationship is implied.

## Funding Release Ledger

Eight controls separate internal meeting readiness from external fundraising release:

- Category and wedge proof.
- Product and technical proof.
- Safety and boundary proof.
- Reconciled financial model and capital plan.
- Entity, IP, cap table, and securities path.
- Permissioned customer and outcome evidence.
- Independent security, clinical, privacy, and regulatory assurance.
- Immutable packet provenance and release authorization.

Product, architecture, and safety preparation can be evidence-ready while the overall fundraising packet remains blocked. Financial reconciliation, qualified legal review, permissioned customer evidence, independent assurance, and immutable release provenance are intentionally weakest-link controls.

## Pitch Architecture

The investor narrative is organized around twelve decision questions: category, workflow problem, entry wedge, product, architecture, trust, proof, market, business model, defensibility, milestones/capital, and company-specific strategic fit. Every slide has proof routes and a claim guard.

## Guided Investor Demonstration

The Investor and Audience Readiness page includes a timed run-of-show that reduces the first meeting to three inspectable proof chapters:

1. Documentation Before Authorization establishes a narrow administrative workflow wedge using synthetic records and no payer submission.
2. Atlas and TrustOS show policy, provenance, human review, auditability, and fail-closed execution as the platform moat.
3. The Demo-to-Pilot Accelerator converts interest into a bounded synthetic evaluation and a controlled diligence decision.

The `3-minute preview` is intended for an executive first meeting. The `12-minute walkthrough` supports technical, product, clinical-operations, or diligence follow-up. Timing is deterministic and tested. Both modes retain the same evidence standard and blocked claims.

An automated rehearsal assessment verifies timebox integrity, chapter order, internal proof-route scope, evidence and decision coverage, and explicit authority boundaries. Passing these checks means the run-of-show is ready for an internal founder rehearsal. Before any external meeting, a human presenter must still confirm the audience and ask, rehearse the live proof routes on the meeting device, validate meeting-specific claims against current evidence and permissions, and keep downloadable artifacts internal unless recipient-specific distribution is separately authorized.

Run `SCRIMED_BASE_URL=https://app.scrimedsolutions.com npm run smoke:investor-demo-proof-routes` before an external presentation. The read-only smoke verifies all nine guided-demo routes, route-specific content, same-origin navigation, no-live-care/no-PHI/no-production-connector response headers, and prohibited-claim absence. Requests, response bodies, and read-only retries are bounded to prevent stalled, oversized, or looping proof checks; operators may tighten the safe defaults with `SCRIMED_SMOKE_REQUEST_TIMEOUT_MS`, `SCRIMED_SMOKE_MAX_RESPONSE_BYTES`, and `SCRIMED_SMOKE_MAX_ATTEMPTS`. Mutation checks remain single-attempt. The smoke stores no page bodies, uses no credentials, performs no mutation, and creates no external distribution or solicitation authority. Its offline and adversarial transport behavior is covered by the nonsecret suite.

The guided demonstration does not authorize external distribution, investment solicitation, customer claims, live PHI, clinical execution, payer submission, EHR writeback, production deployment, or customer activation. A founder or approved human presenter remains responsible for the meeting and every external statement.

The dedicated `/investor-demo-command-room` turns the same plan into a presentation control surface. It runs bounded same-origin proof-route and safety-header checks, requires four reversible presenter confirmations, enforces chapter order, tracks the selected timebox, and generates a browser-local no-PII internal rehearsal receipt only after completion. A passing command-room gate is operational preparation, not independent review, investor approval, solicitation authority, external distribution authority, or evidence of a meeting outcome.

## Competitive Edge

The strongest sellable signals are:

- SCRIMED is a Healthcare Intelligence OS, not a single-feature model wrapper.
- Synthetic-first proof reduces early PHI and procurement friction.
- TrustOS, Claim Guard, release controls, and buyer diligence are productized.
- Investor and clinic audience packaging creates a repeatable capital and sales motion.
- FaithCore gives mission-led clinics a stewardship-centered path with nonprofit and tax review boundaries.
- Enterprise business operations are visible before scale.
- Global certification readiness is mapped without premature approval claims.
- Continuous review and innovation loops compound learning without autonomous production authority.

## Guardrails

This surface is not:

- Investment advice.
- Securities offering material.
- Solicitation.
- Audited financial reporting.
- Valuation assurance.
- Legal, tax, accounting, nonprofit, donor, or grant advice.
- Faith-based endorsement.
- Customer revenue guarantee.
- Profit guarantee.
- Reimbursement assurance.
- Security certification.
- Regulatory approval.
- PHI processing approval.
- Production connector approval.
- Live clinical care authorization.

## Official-Source Alignment

The readiness gates reference current official-source categories that require qualified review before external use:

- SEC private offering and exempt offering guidance.
- SEC accredited investor handling.
- SEC Form D filing awareness.
- SEC Regulation Crowdfunding boundary.
- IRS 501(c)(3) nonprofit exemption requirements.

SCRIMED uses these references to route work to qualified reviewers. The app does not provide legal, tax, accounting, investment, or securities advice.

## Operator Routine

1. Pick the audience packet before any pitch, meeting, or follow-up.
2. Attach proof routes from Product, Growth Engine, Capital Vitality, Business Ops, Public Market Readiness, and protected buyer evidence.
3. Identify blocked claims before the meeting.
4. Route securities, valuation, legal, tax, nonprofit, donor, customer, PHI, clinical, reimbursement, certification, and partnership language through qualified review.
5. Use Claim Guard before any external deck, email, investor memo, PR line, grant narrative, or partner note leaves SCRIMED.
6. Regenerate candidate, source, review-packet, and deck fingerprints after any material change; stale approvals cannot authorize diligence.
